A Clinical Trial Evaluating the Safety and Tolerability, Biodistribution and Radiation Dosimetry, and Pharmacokinetics of Flotufolastat F-18 Injection in Healthy Chinese Adults

Clinical trial NCT07149831 · RECRUITING

Trial details

NCT number: NCT07149831
Sponsor: Sinotau Pharmaceutical Group
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2025-06-07
Primary completion: 2025-12-31
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.